Search
Now showing items 1-10 of 13
Experience With IVDR Implementation in Three Diagnostic Laboratories: Messages to EU Health Institutions, Diagnostic Healthcare Payers, and Authorities
Lubbers, Bart R. et al. (2023)
Wissenschaftlicher Artikel
A Lack of Diversity, Equity, and Inclusion in Clinical Research Has Direct Impact on Patient Care
El-Galaly, Tarec Christoffer et al. (2023)
Wissenschaftlicher Artikel
Palbociclib in Acute Leukemias With KMT2A-rearrangement: Results of AMLSG 23-14 Trial
Gaidzik, Verena Ingeborg et al. (2023)
Wissenschaftlicher Artikel
Outcome of 129 Pregnancies in Polycythemia Vera Patients: A Report of the European LeukemiaNET
Wille, Kai et al. (2023)
Wissenschaftlicher Artikel
Validation of myeloproliferative neoplasms associated risk factor RDW as predictor of thromboembolic complications in healthy individuals: analysis on 6849 participants of the SHIP-study
Manz, Kirsi et al. (2023)
Wissenschaftlicher Artikel
The JAK1/2 inhibitor ruxolitinib in patients with COVID-19 triggered hyperinflammation: the RuxCoFlam trial
Hammersen, J. et al. (2023)
Wissenschaftlicher Artikel
Clinical impact of the genomic landscape and leukemogenic trajectories in non-intensively treated elderly acute myeloid leukemia patients
Jahn, Ekaterina et al. (2023)
Wissenschaftlicher Artikel
Phase I study evaluating the Fc-optimized FLT3 antibody FLYSYN in AML patients with measurable residual disease
Heitmann, Jonas S. et al. (2023)
Wissenschaftlicher Artikel
Activity of decitabine combined with all-trans retinoic acid in oligoblastic acute myeloid leukemia: results from a randomized 2x2 phase II trial (DECIDER)
Rummelt, Christoph et al. (2023)
Wissenschaftlicher Artikel
Measurable residual disease monitoring in patients with acute myeloid leukemia treated with lower-intensity therapy: Roadmap from an ELN-DAVID expert panel
Ravandi, Farhad et al. (2023)
Wissenschaftlicher Artikel